The Surgical Outcome of Distal Pancreatectomy for Distal Pancreatic Tumors

Pancreatic cancer is still associated with poor prognosis and remains a therapeutic challenge and the fourth leading cause of cancer related mortality. Overall long-term survival is about 1–5%, and in only 10–20% of pancreatic cancer patients is potentially curative surgery possible, increasing five-year survival rates to approximately 20–25%. Thirty two patients’ data files were reviewed; those who underwent left sided pancreatectomy for tumor lesions in their pancreatic body or tail in Gastroenterology and Hepatology Hospital & Baghdad Teaching Hospital ,Baghdad, Iraq. for the period from December 2013 up to April 2018. demographics , dates of presentation , ad-mission , presentation features , biochemical investigations , radiological findings , operative findings,histological reports of excised samples and clinical notes regarding postoperative hospitalization period with the postoperative biochemical and radiological findings were analyzed. The result shows most of the resected lesions were benign premalignant tumors with female preponderance and lower mean age of presentation than found in other studies. No significant complications were documented and neither mortality nor recurrence were registered with thrombocytosis was the complication in one case . Successful celiac axis resection done in one case . Most of the cases operated in the 2015 with the non specific abdominal pain being the presenting symptom in more than 30 % of cases . Tumor site was in the tail in about 60 %, and the most common surgical option was distal pancreatectomy with splenectomy . Mucinous cystic neoplasia was the most common tissue diagnosis . Hospital stay was around 5 days in about 33 % of cases.